Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.
about
Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicansA drug-sensitive genetic network masks fungi from the immune systemInterventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infectionInterventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infectionDelaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortalityModulation of phagosomal pH by Candida albicans promotes hyphal morphogenesis and requires Stp2p, a regulator of amino acid transportStructure-Guided Development of Efficacious Antifungal Agents Targeting Candida glabrata Dihydrofolate ReductaseCrystal Structures of Candida albicans Dihydrofolate Reductase Bound to Propargyl-Linked Antifolates Reveal the Flexibility of Active Site Loop Residues Critical for Ligand Potency and SelectivityA new tool to quantify receptor recruitment to cell contact sites during host-pathogen interactionNational surveillance of fungemia in Denmark (2004 to 2009)Epidemiology of invasive candidiasis: a persistent public health problemHospital epidemiology and infection control in acute-care settings.Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.Human serum inhibits adhesion and biofilm formation in Candida albicansRab14 regulates maturation of macrophage phagosomes containing the fungal pathogen Candida albicans and outcome of the host-pathogen interactionAntifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungusCandidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.Candida and invasive candidiasis: back to basics.Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study.Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin.Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.Species distribution and antifungal susceptibility patterns of Candida isolates from a public tertiary teaching hospital in the Eastern Cape Province, South Africa.Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies.Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, IndiaEmergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit.One year prospective survey of Candida bloodstream infections in Scotland.Effect of Delta-9-tetrahydrocannabinol on mouse resistance to systemic Candida albicans infection.In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methodsSeminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.Canadian clinical practice guidelines for invasive candidiasis in adults.Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis.Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.Analysis of the clonality of Candida tropicalis strains from a general hospital in Beijing using multilocus sequence typing.
P2860
Q21090509-3BCD5018-7F45-4395-AB8F-6A655EFA2887Q21131621-39D4F9C3-1762-4381-8784-E932019337B2Q24234875-57A1AB5A-BF89-4591-B640-D31A7593F8BBQ24234997-7788CE8A-5A80-4E8C-8D46-96C566F058C5Q24530412-F3149469-9F12-4339-9C1F-C82828BB1189Q27329992-194091D7-6766-4551-90C8-53DF11E07C2DQ27652249-0EE86640-F8EA-488C-83B4-B9AF0E16B047Q27670663-F6FA3150-6B0D-4A1E-A9B5-380538A656C6Q28539165-24881BB3-186C-4FE0-B312-59570B50686BQ28743556-0D73D178-B18A-4588-B64E-ABAFC11BA1B2Q29616758-D962E08E-8A4B-49CB-B9CA-F5E2DB6EA644Q30429049-529F352A-52CD-453D-A87F-0767EFB8D610Q30447051-995BC168-F75D-4409-BE87-089C719A3982Q30528889-F5E7CDA9-6B0C-47A8-B6D6-2C5525DFDBCDQ30584018-EBA3F1FF-4348-41FA-A056-3B15E3E7686AQ30628883-E161C855-F426-4F6E-973E-1DB006345D4CQ30981454-F644AE0B-4697-4D01-94EB-F0900C58A885Q30998443-771FCEBE-E044-46A7-AA0D-BAC64525F8E5Q33241991-93D7ABAB-7FCF-42A6-8D30-EFEA10941152Q33351140-BE40A0EC-9FD8-41E5-866B-97C0FE31DC83Q33715460-84A64BCB-C4FB-40D1-B038-81ABD72561FEQ33716171-7DBA304E-D82D-4EDA-A033-B506089B5F00Q33753405-2DFA1985-86F7-4751-B92A-E3B7B8EC123CQ33806807-9A73995F-B741-49EF-8353-7990EDCF784CQ33821355-0A235455-1C2B-48CB-A451-CE4C4BDD6F0BQ33825782-FC3409ED-4A5F-4E7D-A6E1-C2303D0362E4Q33851338-D7004C95-3300-486A-8476-0C6A0D62B353Q33856434-3A5DA411-1DF5-4ABC-996C-0901C0829445Q33910250-C40B8E09-EF49-4221-8C50-B05F3392526DQ33946093-98BAA7B8-9388-4B52-8117-B140A4366F14Q34041745-10FA1775-9954-4D2B-A1F7-F380CA9F2DD9Q34042232-9E1F8E47-E7B4-493E-9956-8CADD2464447Q34187320-463F441E-9AA1-4B8F-A31A-CCCFA30A681BQ34228354-B670A3E9-63CD-4134-B745-E09ABA97A582Q34237335-49A2CEAD-D206-4DE5-835C-B8709A38C9E5Q34315530-BE9722BC-E1F3-4B05-84B9-C31AA51B6BA5Q34332272-AEC3364C-BAF9-445F-B775-6E8C7D03B26BQ34372192-C85CDE5A-AB50-4A0F-8984-B450330EC4A4Q34430768-CF0925E8-8F5B-4F30-8C43-56D64BEAC16FQ34477272-7A8DE15C-BCF9-4348-A2AA-185D36303A69
P2860
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Incidence of bloodstream infec ...... d active surveillance program.
@en
Incidence of bloodstream infec ...... d active surveillance program.
@nl
type
label
Incidence of bloodstream infec ...... d active surveillance program.
@en
Incidence of bloodstream infec ...... d active surveillance program.
@nl
prefLabel
Incidence of bloodstream infec ...... d active surveillance program.
@en
Incidence of bloodstream infec ...... d active surveillance program.
@nl
P2093
P2860
P1476
Incidence of bloodstream infec ...... d active surveillance program.
@en
P2093
Andre N Sofair
Beth A Arthington-Skaggs
David W Warnock
G Marshall Lyon
Juliette Morgan
Laurie Thomson Sanza
Lee H Harrison
Lynette E Benjamin
Mary E Brandt
Maureen Phelan
P2860
P304
P356
10.1128/JCM.42.4.1519-1527.2004
P407
P577
2004-04-01T00:00:00Z